Smart Trade Insights
  • Business
  • Economy
  • Investing
  • Politics
Top Posts
Rich Checkan: Gold, Silver Still “Dirt Cheap” —...
Operations update with mine production up 25% QoQ
Dr. Nomi Prins: Gold, Silver, Uranium and More...
Andy Schectman: Reset Happening Now — Gold is...
Biggest Canadian Defense Contractors and ETFs in 2025
5 Best-performing Gold Stocks on the TSX in...
Barrick Mulls Canadian Exit as Mali Gold Tensions...
Apple, MP Materials Ink US$500 Million Deal to...
Silver Price Update: Q2 2025 in Review
Inflation picks up again in June as tariffs...
  • Business
  • Economy
  • Investing
  • Politics

Smart Trade Insights

Business

FDA officially authorizes Zyn nicotine pouches for sale following health review

by admin January 18, 2025
January 18, 2025
FDA officially authorizes Zyn nicotine pouches for sale following health review

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an ‘extensive scientific review’ about their safety.

In a release Thursday, the agency said it had found that the popular pouches posed lower risk of cancer and other serious health conditions compared with cigarettes, as well as in relation to other smokeless tobacco products.

The agency also found that the pouches even had the potential to benefit cigarette smokers amid evidence that they can get them to quit.

‘The data show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products,” Matthew Farrelly, director of the office of science in the FDA’s Center for Tobacco Products, said in a statement. 

Zyn use has exploded in recent years in the wake of a viral online meme trend, even prompting a shortage last year. Yet the product had been operating in a legal gray area while it underwent official FDA review about its health effects and uptake among young users.

To that latter point, the FDA found that, so far, Zyn use among youths appeared to be relatively low, though it was continuing to monitor the trend.

A spokesperson for Philip Morris International Inc., which owns the U.S. rights to Zyn, did not immediately respond to a request for comment.

Swedish Match, the developer of Zyn, said in a statement, “The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.”

The Campaign for Tobacco-Free Kids slammed the FDA’s decision in a separate statement.

‘The FDA today has set a dangerous precedent that puts the nation’s kids at risk by authorizing the sale of 20 Zyn nicotine pouch products with flavors that clearly appeal to kids, including chill, citrus, cool mint and peppermint,’ it said.

‘The FDA’s decision is deeply troubling given the extensive scientific evidence that flavored tobacco products appeal to kids and the fact that nicotine pouches were the only category of tobacco product that saw an increase in youth use last year. The FDA is sanctioning a flavored tobacco product that is already increasing in popularity with kids and repeating the mistakes it made with Juul that resulted in the youth e-cigarette epidemic.’

In the release, the FDA emphasized that its findings about Zyn did not mean the products are ultimately safe or “FDA approved.”

‘There is no safe tobacco product,’ the agency said. ‘Youth should not use tobacco products and adults who do not use tobacco products should not start.’

This post appeared first on NBC NEWS

previous post
Biden Admin Enacts Tougher Regulations for Chip and Connected Vehicle Sectors
next post
Vanguard fined more than $100 million by SEC over violations involving target date retirement funds

You may also like

Ford and Mazda issue do-not-drive warnings for 457,000...

August 14, 2024

New Orleans prepares for Super Bowl 59, its...

February 8, 2025

Caroline Ellison, former FTX exec, sentenced to 2...

September 26, 2024

‘RFK’ing the french fries’: Steak ‘n Shake becomes...

March 18, 2025

JPMorgan Chase CEO Jamie Dimon says DOGE ‘needs...

February 26, 2025

SEC Chair Gary Gensler will step down Jan....

November 23, 2024

Charter rolls out new Spectrum pricing and internet...

September 18, 2024

Costco cracks down on membership card sharing

August 9, 2024

Elon Musk, Tesla, Warner Bros. Discovery sued over...

October 23, 2024

Home prices hit record high in June on...

September 1, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Rich Checkan: Gold, Silver Still “Dirt Cheap” — Best Time to Buy Was Yesterday

      July 17, 2025
    • Operations update with mine production up 25% QoQ

      July 17, 2025
    • Dr. Nomi Prins: Gold, Silver, Uranium and More — I’m Focusing on What’s Real

      July 17, 2025
    • Andy Schectman: Reset Happening Now — Gold is Key, Silver Has Massive Potential

      July 17, 2025
    • Biggest Canadian Defense Contractors and ETFs in 2025

      July 17, 2025
    Promotion Image

    banner ads

    Categories

    • Business (768)
    • Economy (829)
    • Investing (2,432)
    • Politics (737)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smarttradeinsights.com | All Rights Reserved